Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
アンドロゲン依存性疾患を処置するための17β-ヒドロキシステロイドデヒドロゲナーゼタイプ3インヒビター
Document Type and Number:
Japanese Patent JP4614770
Kind Code:
B2
Abstract:
In its many embodiments, the present invention provides a novel class of compounds as illustrated below, wherein the various moieties are described herein, as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase, pharmaceutical compositions containing one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with type 3 17beta-hydroxysteroid dehydrogenase using such compounds or pharmaceutical compositions.

Inventors:
Palchi, Kamil
Guji, Timothy Jay.
Application Number:
JP2004553612A
Publication Date:
January 19, 2011
Filing Date:
November 14, 2003
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Schering Corporation
International Classes:
C07D401/12; A61K31/4545; A61K31/496; A61P5/28; C07D211/46; C07D211/58; A61K31/18; A61K31/506; A61K31/517; A61K31/56; A61P5/26; A61P13/08; A61P17/12; A61P17/14; A61P35/00; A61P43/00
Domestic Patent References:
JP2001521489A
JP2005506356A
JP2005502705A
Other References:
Journal of Enzyme Inhibition and Medicinal Chemistry,2002年,vol.17, No.2,93-100
Attorney, Agent or Firm:
Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita



 
Previous Patent: 新規癌関連遺伝子

Next Patent: JPS4614771